Table 2.
Process evaluation timeline POWER@MS2
| Category of participants | Measurement time points | ||||||||||
| Screening | Baseline | ||||||||||
| Month | v-1 | v0 | v1 | v2 | v3 | v4 | v5 | v6 | v7 | v8 | vx |
| −1 | 0 | 3 | 6 | 9 | 12 | 15 | 18 | 21 | 24 | X | |
| Non-participation study centres | × | ||||||||||
| Centres structures/processes | × | ||||||||||
| Evaluation neurologists | × | × | × | ||||||||
| Evaluation study nurses | × | × | |||||||||
| Evaluation trained MS nurse | × | × | |||||||||
| Non-participation PwMS | × | (×) | (×) | (×) | (×) | (×) | (×) | (×) | (×) | (×) | (×) |
| Evaluation PwMS | × | × | × | × | × | ||||||
| Evaluation dropouts | (×) | (×) | (×) | (×) | (×) | (×) | (×) | (×) | (×) | (×) | |
| Evaluation stakeholders | × | ||||||||||
(×), optional visits; MS, multiple sclerosis; PwMS, people with multiple sclerosis; v0, visit directly after enrolment; v-1, visit before enrolment; v1, visit in month 3; v2, visit in month 6; v3, visit in month 9; v4, visit in month 12; v5, visit in month 15; v6, visit in month 18; v7, visit in month 21; v8, visit in month 24; vx, visit after the final participant reaches v4 (all participants, who have not reached v8).